News from nkt therapeutics

Dec 09, 2013, 10:10 ET

NKT Therapeutics' Identifies Novel anti-iNKT Antibodies for Depleting or Activating iNKT Cells

 NKT Therapeutics (NKTT) today presented research results with NKT14 and NKT14m, monoclonal antibodies designed to deplete (NKT14) or activate...

Dec 07, 2013, 10:00 ET
NKT Therapeutics logo.  (PRNewsFoto/NKT Therapeutics)

NKT Therapeutics Reports First Clinical Results with anti-iNKT Antibody in Patients with Sickle Cell Disease

NKT Therapeutics today announced the presentation of initial clinical results with NKTT120, a monoclonal antibody designed to suppress the chronic...

Dec 08, 2012, 09:00 ET
NKT Therapeutics logo.  (PRNewsFoto/NKT Therapeutics)

NKT Therapeutics Presents Data on Potential Antibody Treatment for Sickle Cell Disease

NKT Therapeutics, Inc., a privately held biotechnology company, announced preclinical study results supporting the potential of its lead...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets